Navigation Links
Allergic Rhinitis Associated with Impaired Sleep Quality

CHICAGO - Patients with allergic rhinitis, such as that caused by hay fever and other allergies, have more difficulty sleeping and more sleep disorders// than those without allergies, according to a report in the September 18 issue of Archives of Internal Medicine, a theme issue on sleep.

Allergic rhinitis, which occurs when pollen or other allergens irritate and inflame the nasal passages, affects about 20 to 50 percent of the population, according to background information in the article. Allergies have been shown to affect quality of life and several studies have suggested that they may contribute to snoring and breathing problems during sleep, including sleep apnea, a temporary halt to breathing. However, few researchers have closely examined sleep disorders in patients with allergic rhinitis.

Damien L?ger, M.D., of Assistance Publique H?pitaux de Paris, and colleagues explored the association between allergic rhinitis and sleep in 591 patients (47 percent men, 53 percent women, average age 34) who had the condition for at least one year and who were being treated by an allergist or by an ear, nose and throat specialist. A control group of 502 individuals who were the same age and sex and lived in the same area, but did not have allergic rhinitis, was also assessed. In 2002, all participants reported sleep disorders and rated their sleepiness; they also provided details regarding demographics, socioeconomic status and smoking habits. For patients with allergic rhinitis, researchers recorded the type of allergies, the duration of the condition, symptoms experienced and treatments used, as well as the presence and treatment of any additional allergic disorders.

All sleep disorders and complaints-including insomnia, waking up during the night, snoring and feeling fatigued when awakening-were more common in those with allergic rhinitis, who also slept fewer hours, took longer to fall asleep and more often felt sleepy during
'"/>




Page: 1 2

Related medicine news :

1. Diet Can Influence Allergic Skin Reactions
2. New Treatment For People Allergic To Cats
3. Red Color Causes The Allergic Reaction To Strawberries
4. New Insight Gained For Allergic Reactions
5. Anthroposophical Lifestyle Reduces Risk Of Allergic Disease In Children
6. Allergic reaction to DTaP vaccine persists in children
7. Number of Allergic Anaphylaxis Episodes Are Far More Than Those Recorded
8. Eye Drug Macugen Shows Allergic Reactions
9. Allergic to Kisses?
10. Preventive Measures Proved Ineffective in Allergic Children
11. New Cooperative Research Center for Allergic Disease
Post Your Comments:
Other Medicine News:Health News:Americans United for Life Condemns Ruling Increasing Minors' Access to Dangerous Plan B 2Health News:AANS President to Testify on Patient Access to Care 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 3Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 4Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 5Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 6Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 7Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 8Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 9Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 10Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 11Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 12Health News:Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultz's 'The Early Act' 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 3
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 1Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 2Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 3Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 1Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 3SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 1SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 2SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 3